ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FUM Futura Medical Plc

35.65
0.15 (0.42%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 0.42% 35.65 35.40 35.90 36.50 34.05 36.50 425,707 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -18.25 106.45M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 35.50p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £106.45 million. Futura Medical has a price to earnings ratio (PE ratio) of -18.25.

Futura Medical Share Discussion Threads

Showing 16601 to 16614 of 21425 messages
Chat Pages: Latest  665  664  663  662  661  660  659  658  657  656  655  654  Older
DateSubjectAuthorDiscuss
08/2/2023
21:34
Medical device claims claims that breach CAP Code (Edition 12) rules 3.1 (Misleading advertising), 3.7 (Substantiation) and 12.1 Medicines, medical devices

‘Because the trial was not placebo-controlled’

‘had not provided adequate evidence to support the claim’ ˜clinically proven’ ˜concluded that the claim had not been substantiated and was misleading’




Assessment

Upheld

The ASA noted that the product appeared to meet the requirements of the Medical Device Directive (MDD) but understood that the MDD did not harmonise EU law relating the advertising of medical devices, which was subject to Directive 2005/29/EC on unfair business to consumer commercial practices (including advertising) generally (Unfair commercial practices directive - UCPD). That meant that advertisers must still meet the requirements of the CAP Code, which reflected the provisions of UCPD. Under the CAP and BCAP Codes, medical claims could be made for CE-marked medical devices provided they complied with other requirements of the Codes, including those relating to substantiation.

CE certification in itself does not constitute evidence for medical efficacy claims, and advertisers need to ensure that they hold evidence for such claims.

There was no statistically significant difference between the outcomes for the treatment group (patients using the Aerosure device) and the control group (using an inactive sham device). The study was accordingly not adequate evidence of the efficacy




Because the trial was not placebo-controlled, we considered AcceleDent had not provided adequate evidence to support the claim AcceleDent, is also clinically proven to reduce the pain and discomfort associated with braces and aligners by up to 71%. We concluded that the claim had not been substantiated and was misleading.

On that point the claim breached CAP Code (Edition 12) rules 3.1 (Misleading advertising), 3.7 (Substantiation) and 12.1 Medicines, medical devices, health-related products and beauty products.



Assessment

Upheld

The ASA noted that the product appeared to meet the requirements of the Medical Device Directive (MDD) but understood that the MDD did not harmonise EU law relating the advertising of medical devices, which was subject to Directive 2005/29/EC on unfair business to consumer commercial practices (including advertising) generally (Unfair commercial practices directive - UCPD). That meant that advertisers must still meet the requirements of the CAP Code, which reflected the provisions of UCPD. Under the CAP and BCAP Codes, medical claims could be made for CE-marked medical devices provided they complied with other requirements of the Codes, including those relating to substantiation.

CE certification in itself does not constitute evidence for medical efficacy claims, and advertisers need to ensure that they hold evidence for such claims.

There was no statistically significant difference between the outcomes for the treatment group (patients using the Aerosure device) and the control group (using an inactive sham device). The study was accordingly not adequate evidence of the efficacy

lbo
08/2/2023
21:30
This is what the stock basher LiarBO said about reviewers posting on the Farmaline website:

LBO - 26 Jan 2023 - 11:40:29 - 15917 of 16267 FUTURA a winner for 2015 - FUM
But he was involved in the tests! Presumably the consumer HUT. Or are you now claiming an online pharmacy website is allowing inaccurate reviews of the product?

hxxps://www.farmaline.be/apotheek/bestellen/eroxon/

So LiarBO is stating that the man who gave Eroxon a 5 star report gave an accurate review of the product. Interestingly, LiarBO's favourite Dutchman who initially left a 3 star review has come back and left another 'accurate review'. This time he tried Eroxon when he was 'not in the mood' and still confirmed that it works. In fact, he gave it another star! 4 stars for giving him wood when he wasn't in the mood!

LiarBO will of course bleat that any old gel would do the same - if that were true why would these officially certified customers fork out thirty Euros when they could have bought a tube of KY?

petroc
08/2/2023
20:13
Yes I saw the reviews too Petroc, good stuff, everything moving rapidly in the right direction.

I'm not concerned about what the bitter loser cuts and pastes, I've had him on filter for a long time now......but that is hilarious lolllll

;-)

broomrigg
08/2/2023
18:17
This is what the stock basher LiarBO said about reviewers posting on the Farmaline website:

LBO - 26 Jan 2023 - 11:40:29 - 15917 of 16267 FUTURA a winner for 2015 - FUM
But he was involved in the tests! Presumably the consumer HUT. Or are you now claiming an online pharmacy website is allowing inaccurate reviews of the product?

hxxps://www.farmaline.be/apotheek/bestellen/eroxon/

So LiarBO is stating that the man who gave Eroxon a 5 star report gave an accurate review of the product. Interestingly, LiarBO's favourite Dutchman who initially left a 3 star review has come back and left another 'accurate review'. This time he tried Eroxon when he was 'not in the mood' and still confirmed that it works. In fact, he gave it another star! 4 stars for giving him wood when he wasn't in the mood!

LiarBO will of course bleat that any old gel would do the same - if that were true why would these officially certified customers fork out thirty Euros when they could have bought a tube of KY?

petroc
08/2/2023
18:00
Did you read the 5 star review as well, Broomrigg? LiarBO has already informed us that people leaving reviews on that website are trusted and verified!
petroc
08/2/2023
17:24
keifer derrin8

"according to LSE BB the product is going on sale on the 14 February on Farmaline
(hxxps://www.farmaline.be/pharmacie/produits/eroxon/)"

Thanks for the link.

Yes the website says Eroxon will be on sale from 14th Feb. Here is what it says on the website (translated).....

"New ! Expected delivery from February 14, 2023.
Eroxon® is a clinically proven treatment for erectile dysfunction for men (aged 18 and over). Helps to have an erection in 10 minutes."

If it's going on sale there then surely it will be available in other places too?

:-)

broomrigg
08/2/2023
16:37
we have to get past 55p and hold before it will go higher...

but according to LSE BB the product is going on sale on the 14 February on Farmaline
(hxxps://www.farmaline.be/pharmacie/produits/eroxon/), so this could give it the boost it needs.....

keifer derrin
08/2/2023
15:59
70p even better and with the news that is expected 100p will look cheap ;-)
broomrigg
08/2/2023
15:45
Very close to a breakout from the pennant.

First pause likely 70p territory

amelio
08/2/2023
15:42
Next spike up past 60p looking good.....and with news easily 100p plus :-)
broomrigg
08/2/2023
15:21
Hahahahaha! You deceitful idiot, LiarBO! You just don't know know when you're beat, do you! Hahahahaha!
petroc
08/2/2023
13:17
Some swindle by the rampers!



Proof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer. FTC v. QT, Inc.



Ingredients Water, ethanol (35%), propylene glycol, glycerin, carbomer, potassium hydroxide.

After a few moments there was a slight sensation of "cold and heat". Anyone who knows the more special lubricants









water-based warming gel Ingredients

Stimulant Gel Aqua, Glycerin, Propylene Glycol, Alcohol Denat, Carbomer

lbo
08/2/2023
12:49
Do you remember LiarBO's favourite website review on Farmaline? The Dutchman (who didn't have ED) that LiarBO held up as a paragon of unbiased and certified user? He'll be interested to learn that another certified and unbiased user has posted another genuine review.

hxxps://www.farmaline.be/apotheek/bestellen/eroxon/


5/5
Fantastic !
Tested the product and it worked great within 5 minutes !! Great product !!!

Oh dear, LiarBO! I suppose you'll now tell us that they're lying, along with over 60% of men with ED who've trialled Eroxon and confirmed that it works!

petroc
08/2/2023
12:06
Seriously nice looking Bullish pennant forming on the chart.

Only a matter of time now before a breakout.

amelio
Chat Pages: Latest  665  664  663  662  661  660  659  658  657  656  655  654  Older

Your Recent History

Delayed Upgrade Clock